Podcast Highlights

Treating the AD Patient During COVID-19

By November 6, 2020November 10th, 2020No Comments

JDD Multimedia

JDD Podcast

Listen Now

How to Listen

Treating the AD Patient During COVID-19

Dr. Peter Lio and Dr. Adam Friedman

 

Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children and adults in the United States alone and requires a tailored treatment plan and ongoing follow up. Now add a global pandemic to the mix – awesome.

Join podcast host Dr Adam Friedman and atopic dermatitis antagonist Dr. Peter Lio as they discuss practical approaches to managing atopic dermatitis in the era of COVID-19. Telemedicine, topicals, and tons of systemic talk!

Listen Now
This podcast is supported by an independent medical education grant provided by Sanofi Genzyme Regeneron.

 

Learning Objectives:
Upon completion of this podcast, learners should be able to:
  • Formulate AD treatment plans that may decrease susceptibility and spread of viral infections, including COVID-19
  • Identify new and emerging therapeutic considerations for managing atopic dermatitis during the current COVID-19 pandemic

You May Also Like

Treating the AD Patient During COVID-19

| Podcast Highlights | No Comments
iTunes Google Play Stitcher TuneIn Dr. Peter Lio and Dr. Adam Friedman   Atopic dermatitis is a relentless, recurring, unreasonable, often recalcitrant inflammatory skin disease that impacts millions of children…

Understanding and Changing Patient Behavior and Minimizing Risk of UV Damage

| Podcast Highlights, Skin Cancer | No Comments
iTunes Google Play Stitcher TuneIn Drs. Sherry Pagoto and Adam Friedman   Why is is that we tend to do things we know are bad for us? Candy, alcohol, Tinder...the…

NEW from the JDD Podcast: “The Science of Sun Protection”

| Photoprotection, Podcast Highlights, Skin Cancer | No Comments
iTunes Google Play Stitcher TuneIn Dr. Neal Bhatia and Dr. Adam Friedman   Photoprotection works, plain and simple. Yet all too often we must defend good science, dispel unfounded myths,…